Au contraire…The most important trial results ARE…HITTING THE ENDPOINTS! <br /> <br /> Cytodyn has not done that in the CoVID trials and is struggling mightily to fill BRAZIL trials which were touted as a sure thing. LMAO. <br /> <br /> THE ONLY SURE THING WITH CYDY IS THAT NADER AND INSIDERS GET PAID! <br /> <br /> The facts are the mortality rate of CoVID, from a medical perspective, is nominal and effective treatments are emerging to treat most cases. (Not minimizing individual CoVID horror stories, looking at the economics) <br /> <br /> The CoVID play is history. No results possible until end of 2022 with the pace of the Brazil trial enrollment. <br /> <br /> Enrollment is as mush as 5 times slower than expected. <br /> <br /> The road to cancer and NASH will be long and difficult. HIV was a lock and somehow Nader pulled defeat from the jaws of victory. ( Oh yeah, he won about $15mil worth from that fiasco). <br /> <br /> Nader does not possess the skills necessary to compete in cancer.